Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Evaluation of See.d Pre-Analytical Platform Performance: From Whole Blood to Plasma and SBS Slides for Liquid Biopsy Applications

NCT06097156 is registered in ClinicalTrials.gov with Tethis S.p.A. as lead sponsor.

NCT NCT06097156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06097156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Evaluation of See.d Pre-Analytical Platform Performance: From Whole Blood to Plasma and SBS Slides for Liquid Biopsy Applications
Lead sponsor
Tethis S.p.A.
Phase
Observational
Overall status
Recruiting
Start date
November 6, 2023
Completion date
December 31, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, healthy participants